Jim Cramer's top 10 things to watch in the stock market Wednesday
Moderna is soaring after promising results for its cancer vaccine. Plus, Target may be victim to profit-taking.
Moderna is soaring after promising results for its cancer vaccine. Plus, Target may be victim to profit-taking. This story matters for Finance & Markets readers tracking trade. Reported by cnbc.com. Read the full original at the source link below.
Originally reported by cnbc.com. Trade-News curates and briefs the finance & markets stories that matter. Our editorial policy →